WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for APRE

Based on 2 analysts offering 12 month price targets for Aprea Therapeutics Inc.
Min Forecast
$16.00+343.21%
Avg Forecast
$18.00+398.61%
Max Forecast
$20.00+454.02%

Should I buy or sell APRE stock?

Based on 2 analysts offering ratings for Aprea Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APRE stock forecasts and price targets.

APRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 10%
91
BuyReiterates$20.00+454.02%2023-05-16
Maxim Group
Bottom 3%
3
Strong BuyInitiates Coverage On$16.00+343.21%2023-03-10

1 of 1

Forecast return on equity

Is APRE forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.96%

Forecast return on assets

Is APRE forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

APRE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APRE$3.61$18.00+398.61%Strong Buy
UPC$0.62N/AN/A
AEZS$2.75$28.00+918.55%Buy
FREQ$0.37$5.50+1,386.49%Strong Buy
ATHE$2.85N/AN/A
View Top Biotech Stocks

Aprea Therapeutics Stock Forecast FAQ

Is Aprea Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: APRE) stock is to Strong Buy APRE stock.

Out of 2 analysts, 1 (50%) are recommending APRE as a Strong Buy, 1 (50%) are recommending APRE as a Buy, 0 (0%) are recommending APRE as a Hold, 0 (0%) are recommending APRE as a Sell, and 0 (0%) are recommending APRE as a Strong Sell.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.

What is APRE's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: APRE) forecast ROE is N/A, which is considered weak.

What is APRE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year APRE price target, the average APRE price target is $18.00, with the highest APRE stock price forecast at $20.00 and the lowest APRE stock price forecast at $16.00.

On average, Wall Street analysts predict that Aprea Therapeutics's share price could reach $18.00 by May 16, 2024. The average Aprea Therapeutics stock price prediction forecasts a potential upside of 398.61% from the current APRE share price of $3.61.

What is APRE's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: APRE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.